Abstracting and Indexing

  • PubMed NLM
  • Google Scholar
  • Semantic Scholar
  • Scilit
  • CrossRef
  • WorldCat
  • ResearchGate
  • Academic Keys
  • DRJI
  • Microsoft Academic
  • Academia.edu
  • OpenAIRE
  • Scribd
  • Baidu Scholar

Association between COVID-19 Vaccine and New-Onset Atrial Fibrillation

Author(s): Kunal M. Ajmera

Since the availability of the vaccine against severe acute respiratory syndrome, coronavirus 2 (SARS-CoV-2), the etiologic agent for COVID-19, at least 67% of the US population has been vaccinated with at minimum one dose, and 58.2% of the U.S. population has received two doses. Here, we present the first report of a patient who developed new-onset atrial fibrillation (AF) after receiving a booster dose of the Moderna COVID-19 vaccine. The benefit of the COVID-19 vaccine certainly outweighs the risks of adverse cardiac effects; however, recipients with known cardiac risk factors should be appropriately advised. The mechanism by which the COVID-19 vaccine causes adverse cardiac effects is presently unknown and is likely complex and multifactorial. Prospective studies are needed urgently to understand the mechanism and pathophysiology of such serious adverse events.

Journal Statistics

Impact Factor: * 3.5

CiteScore: 2.9

Acceptance Rate: 14.80%

Time to first decision: 10.4 days

Time from article received to acceptance: 2-3 weeks

Discover More: Recent Articles

Grant Support Articles

© 2016-2024, Copyrights Fortune Journals. All Rights Reserved!